Skip to main content
. 2021 Feb 11;9(1):47–56. doi: 10.14744/nci.2021.65725

Table 3.

Comparison of WBRT and SBRT

WBRT (n=24) SRS (n=17) p
  WBRT SRS p (n=24) (n=17)
Characteristics of patients
 Age
  <65 66.7 52.9 0.375
  ≥65 33.3 47.1
 Sex
  Male 33.3 82.4 0.002
  Female 66.7 17.6
 Primary tumor
  Colon 8.3 41.2 0.027
  Rectum 16.7 23.5
  Stomach 50 23.5
  Esophagus 4.2 5.9
  Pancreas 16.7 0
  Bile duct 0 5.9
  Rectosigmoid 4.2 0
 Histology
  Adenocarcinoma 87.5 94.1
  Squamous 4.2 5.9
  Neuroendocrine 8.3 0
 KPS* 0.003
 KPS
  ≤70 41.7 5.9 0.014
  >70 58.3 94.1
 ds-GPA score 0.038
  ds-GPA=1 37.5 5.9
  ds-GPA=2 41.7 47.1
  ds-GPA=3 20.8 47.1
  ds-GPA=4 0 0
 GI-GPA score 0.035
  GI-GPA=0 37.5 5.9
  GI-GPA=1 41.7 35.3
  GI-GPA=2 16.7 47.1
  GI-GPA=3 4.2 11.8
 Systemic disease status at diagnosis of BM
  Controlled 20.8 29.4 0.714
  Uncontrolled 79.2 70.6
 Extracranial metastasis
  Lung 37.5 68.7 0.053
  Bone 25 35.7 0.712
  Liver 54.2 46.2 0.642
  Systemic lymph node 41.7 15.4 0.103
  Skin 0 7.7 0.351
  Adrenal gland 12.5 0 0.538
 Interval from diagnosis to extracranial metastasis* 0
(r: 0–36)
10
(r: 0–49)
0.017
 Median OS (months) 4 9 0.005
Characteristics of BM
 Interval from diagnosis to BM* (months) 9 (0–40) 20 (0–60) 0.008
 Number of metastasis
  1 25 58.8 0.102
  2 25 11.8
  ≥3 50 29.4
 Location of BM
  Supratentorial 45.8 52.9 0.497
  Infratentorial 25 35.3
  Both 29.2 11.8
 Volume of BM (cc)* 45.9
(r: 0.34–112)
6.4
(r: 0.46–19.9)
0.024
 Volume of BM (cc)
  <10 cc 37.5 70.6 0.037
  ≥10 cc 62.5 29.4
  Edema 75 76.5 1
  Hemorrhage 37.5 41.2 0.812

*: Median (minimum–maximum); BM: Brain metastasis; ds-GPA: Diagnosis-specific graded prognostic assessment; GI-GPA: Gastrointestinal graded prognostic assessment; KPS: Karnofsky performance status; OS: Overall survival; SRS: Stereotactic radiosurgery; WBRT: Whole-brain radiotherapy; r: Range.